Autoimmune hepatitis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 21: | Line 21: | ||
**[[Autoimmune hepatitis]] is common who are infected with the [[measles]], [[herpes simplex]] or [[Epstein Barr virus|epstein-Barr virus]] and [[hepatitis A]], B or C infection in the past | **[[Autoimmune hepatitis]] is common who are infected with the [[measles]], [[herpes simplex]] or [[Epstein Barr virus|epstein-Barr virus]] and [[hepatitis A]], B or C infection in the past | ||
*History of drug intake:<ref name="pmid20512992">{{cite journal |vauthors=Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K |title=Drug-induced autoimmune hepatitis: clinical characteristics and prognosis |journal=Hepatology |volume=51 |issue=6 |pages=2040–8 |year=2010 |pmid=20512992 |doi=10.1002/hep.23588 |url=}}</ref> | *History of drug intake:<ref name="pmid20512992">{{cite journal |vauthors=Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K |title=Drug-induced autoimmune hepatitis: clinical characteristics and prognosis |journal=Hepatology |volume=51 |issue=6 |pages=2040–8 |year=2010 |pmid=20512992 |doi=10.1002/hep.23588 |url=}}</ref> | ||
**[[ | **[[minocycline]], [[nitrofurantoin]], [[hydralazine]], [[methyldopa]] [[statins]], [[fenofibrate]], [[interferon]], [[infliximab]], [[etanercept]] increases the risk of [[autoimmune hepatitis]]. | ||
==References== | ==References== | ||
Revision as of 17:18, 9 January 2018
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis risk factors On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis risk factors |
|
Risk calculators and risk factors for Autoimmune hepatitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Common risk factors in the development of autoimmune hepatitis include female gender, Genetic predisposition associated with HLA-DR3 and HLA-DR4, and history of other autoimmune hepatitis eg thyroiditis, type 1 diabetes, ulcerative colitis, celiac disease, and rheumatoid arthritis.
Risk Factors
Common Risk Factors
Common risk factors in the development of autoimmune hepatitis include:
- Females:
- Autoimmune hepatitis is more common in young females
- Genetic predisposition:[1]
- History of another autoimmune disease:[2]
- Autoimmune diseases, including thyroiditis, type 1 diabetes, ulcerative colitis, celiac disease, and rheumatoid arthritis
Less Common Risk Factors
Less common risk factors in the development of Autoimmune hepatitis include:
- A history of viral infections:[3][4]
- Autoimmune hepatitis is common who are infected with the measles, herpes simplex or epstein-Barr virus and hepatitis A, B or C infection in the past
- History of drug intake:[5]
- minocycline, nitrofurantoin, hydralazine, methyldopa statins, fenofibrate, interferon, infliximab, etanercept increases the risk of autoimmune hepatitis.
References
- ↑ Donaldson PT (2004). "Genetics of autoimmune and viral liver diseases; understanding the issues". J. Hepatol. 41 (2): 327–32. doi:10.1016/j.jhep.2004.06.001. PMID 15288484.
- ↑ "Autoimmune hepatitis - PubMed Health". Retrieved 2013-01-02.
- ↑ Vento S, Cainelli F (2004). "Is there a role for viruses in triggering autoimmune hepatitis?". Autoimmun Rev. 3 (1): 61–9. doi:10.1016/S1568-9972(03)00053-3. PMID 14871651.
- ↑ Huppertz HI, Treichel U, Gassel AM, Jeschke R, Meyer zum Büschenfelde KH (1995). "Autoimmune hepatitis following hepatitis A virus infection". J. Hepatol. 23 (2): 204–8. PMID 7499793.
- ↑ Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K (2010). "Drug-induced autoimmune hepatitis: clinical characteristics and prognosis". Hepatology. 51 (6): 2040–8. doi:10.1002/hep.23588. PMID 20512992.